Importance

Loading Importance Indicators...

Abstract

The invention relates to treatment of patients in need of increasing insulin sensitivity by administration of growth hormone or analogues thereof, preferably human growth hormone, in a low dose and the use of growth hormone or analogues thereof, preferably human growth hormone, for the manufacturing of a medicament useful for increasing insulin sensitivity in low dose therapy.The patient is preferably a normal subject, i.e. not growth hormone deficient patient and/or a non-obese patients.By low dose therapy is preferably meant less than 0.008 mg/kg/day, preferably 0.007 mg/kg/day or less, more preferably 0.005 mg/kg/day or less and most preferably 0.003 mg/kg/day or less.The therapy is preferably performed during short term treatment, preferably less than one month.

Loading the Abstract Image...

First Claim